This session aims to illuminate the cutting-edge technical approaches of AI-driven biologics drug discovery companies. Speakers will explore the ongoing R&D efforts in developing platforms and pipelines, delineate their roles within the life sciences industry, and provide insights into the current competitive landscape. Additionally, speakers will facilitate a robust discussion to critically examine the challenges and limitations of various AI approaches in the current biologics drug discovery landscape, encouraging a deeper comprehension and engagement from all attendees. The session will also offer industry experts early insights into advanced developments, fostering opportunities for involvement and collaboration.

Lunch available following the session in room while supplies last.